Hoffmann-La Roche: Influenza, Human trials
The registry lists 22 Influenza, Human studies with Hoffmann-La Roche as lead sponsor. 2 are open to participants now and 16 have results posted.
Phase 1 4Phase 2 2Phase 3 10Phase 4 4No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese ParticipantsRecruitingNCT07827599Phase 3
- A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household ContactsRecruitingNCT06094010Phase 3
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza SymptomsCompletedNCT06774859Phase 3Results posted
- Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in HouseholdsCompletedNCT03969212Phase 3Results posted
- Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe InfluenzaCompletedNCT03684044Phase 3Results posted
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like SymptomsCompletedNCT03653364Phase 3Results posted
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like SymptomsCompletedNCT03629184Phase 3Results posted
- A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy AdultsCompletedNCT02623322Phase 2Results posted
- A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A InfectionCompletedNCT02293863Phase 2Results posted
- A Study of Intravenous Oseltamivir [Tamiflu] in Infants With InfluenzaTerminatedNCT01053663Phase 1Results posted
- A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With InfluenzaCompletedNCT01050257Phase 3Results posted
- A Study of Intravenous Tamiflu (Oseltamivir) in Children With InfluenzaCompletedNCT01033734Phase 1Results posted
- A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu StrainTerminatedNCT01032837Phase 4Results posted
- A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu InfectionCompletedNCT00988325Phase 1Results posted
- A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal InfluenzaCompletedNCT00949533Phase 3Results posted
- Influenza Resistance Information StudyCompletedNCT00884117Results posted
- A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.CompletedNCT00545532Phase 3Results posted
- A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised ParticipantsCompletedNCT00412737Phase 4Results posted
- A Retrospective, Observational Registry of Participants With Avian Influenza InfectionCompletedNCT02743676
- A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza InfectionCompletedNCT01715909Phase 1
- A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.TerminatedNCT00436124Phase 4
- A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.CompletedNCT00412555Phase 4